Hypothalamic dopaminergic stimulation in cluster headache

Cephalalgia

Volumn 33, Issue 14, 2013, Pages 1155-1159

  Lepper, Anne ^a   Frese, Achim ^a,b   Summ, Oliver ^a   Nofer, Jerzy Roch ^a   Evers, Stefan ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Akademie fur Manuelle Medizin   (Germany)

Author keywords

apomorphine; Cluster headache; cortisol; growth hormone; prolactin

Indexed keywords

APOMORPHINE; GROWTH HORMONE; HYDROCORTISONE; PROLACTIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; EPISODIC CLUSTER HEADACHE; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS; PROLACTIN BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

APOMORPHINE; CLUSTER HEADACHE; CORTISOL; GROWTH HORMONE; PROLACTIN;

ADULT; CLUSTER HEADACHE; DOPAMINE; DOPAMINE AGONISTS; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOTHALAMUS; MALE; MIDDLE AGED; PROLACTIN;

EID: 84885005851     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102413487445     Document Type: Article

References (22)

1. Matharu M, May A. Functional and structural neuroimaging in trigeminal autonomic cephalalgias. Curr Pain Headache Rep. 2008 ; 12: 132-137
2. Leone M, Bussone G. Pathophysiology of trigeminal autonomic cephalalgias. Lancet Neurol. 2009 ; 8: 755-764
3. Leone M, Bussone G. A review of hormonal findings in cluster headache. Evidence for hypothalamic involvement. Cephalalgia. 1993 ; 13: 309-317
4. Stillman M, Spears R. Endocrinology of cluster headache: Potential for therapeutic manipulation. Curr Pain Headache Rep. 2008 ; 12: 138-144
5. Holle D, Obermann M. Cluster headache and the hypothalamus: Causal relationship or epiphenomenon. Expert Rev Neurother. 2011 ; 11: 1255-1263
6. Corn TH, Hale AS, Thompson C, et al. A comparison of the growth hormone responses to clonidine and apomorphine in the same patients with endogenous depression. Br J Psychiatry. 1984 ; 144: 636-639
7. Hughes AJ, Lees AJ, Stern GM. Challenge test to predict the dopaminergic response in untreated Parkinson's disease. Neurology. 1991 ; 41: 1723-1725
8. Gasser T, Schwarz J, Arnold G, et al. Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease. Arch Neurol. 1992 ; 49: 1131-1134
9. Clarke CE, Davies P. Systematic review of acute levodopa and apomorphine challenge tests in the diagnosis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 2000 ; 69: 590-594
10. Friess E, Kümpfel T, Winkelmann J, et al. Increased growth hormone response to apomorphine in Parkinson's disease compared with multiple system atrophy. Arch Neurol. 2001 ; 58: 241-246
11. Happe S, Bachmann CG, Helmschmied K, et al. Growth hormone response to low-dose apomorphine in restless legs syndrome. Growth Horm IGF Res. 2007 ; 17: 323-327
12. Anderson LL, Scanes CG. Nanobiology and physiology of growth hormone secretion. Exp Biol Med. 2012 ; 237: 126-142
13. Brown WA, Van Woert MH, Ambani LM. Effect of apomorphine on growth hormone release in humans. J Clin Endocrinol Metab. 1973 ; 37: 463-465
14. Brown WA, Krieger DT, Van Woert MH, et al. Dissociation of growth hormone and cortisol release following apomorphine. J Clin Endocrinol Metab. 1974 ; 38: 1127-1130
15. Lal S, De La Vega CE, Sourkes TL, et al. Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum. J Clin Endocrinol Metab. 1973 ; 37: 719-724
16. Meyer EL, Marcus C, Waldenlind E. Nocturnal secretion of growth hormone, noradrenaline, cortisol and insulin in cluster headache remission. Cephalalgia. 2007 ; 27: 912-919
17. Pinessi L, Rainero I, Valfrè W, et al. Abnormal 5-HT1D receptor function in cluster headache: A neuroendocrine study with sumatriptan. Cephalalgia. 2003 ; 23: 354-360
18. Cerbo R, Barbanti P, Buzzi MG, et al. Dopamine hypersensitivity in migraine: Role of the apomorphine test. Clin Neuropharmacol. 1997 ; 20: 36-41
19. Charbit AR, Akerman S, Goadsby PJ. Dopamine: What's new in migraine. Curr Opin Neurol. 2010 ; 23: 275-281
20. Boiardi A, Bussone E, Martini A, et al. Endocrinological responses in cluster headache. J Neurol Neurosurg Psychiatry. 1983 ; 46: 956-958
21. Rainero I, Ferrero M, Rubino E, et al. Endocrine function is altered in chronic migraine patients with medication-overuse. Headache. 2006 ; 46: 597-603
22. Happe S, Tings T, Koch W, et al. Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson's disease. J Neural Transm. 2007 ; 114: 589-594